The Centers for Disease Control and Prevention today released new data showing a total of 1,447,520 reports of adverse events following COVID-19 vaccines were submitted between Dec. 14, 2020, and Oct. 21, 2022, to the Vaccine Adverse Event Reporting System.
VAERS is the primary government-funded system for reporting adverse vaccine reactions in the U.S. The data included a total of 31,696 reports of deaths and 263,462 serious injuries, including deaths, during the same time period.
There were a total of 5,435 reports of adverse events following the new COVID-19 bivalent booster as of Oct. 21, 2022.
VAERS data from Dec. 14, 2020, to Oct. 21, 2022, for 6-month-olds to 5-year-olds show: 4,482 adverse events, including 187 cases rated as serious and 8 reported deaths.
VAERS data from Dec. 14, 2020, to Oct. 21, 2022, for 5- to 11-year-olds show: VAERS data from Dec. 14, 2020, to Oct. 21, 2022, for 12- to 17-year-olds show: 40,045 adverse events, including 4,358 rated as serious and 129 reported deaths.
According to the CDC, "VAERS data available to the public include only the initial report data to VAERS. Updated data which contains data from medical records and corrections reported during follow up are used by the government for analysis. However, for numerous reasons including data consistency, these amended data are not available to the public."
The FDA took more than a year to follow up on a potential increase in serious adverse events in elderly people who received Pfizer's COVID-19 vaccine, according to an investigative report published Tuesday by The BMJ. According to The BMJ, in July 2021, the FDA "Quietly disclosed" the findings of a potential increase in four types of serious adverse events in elderly people who had received a Pfizer COVID-19 vaccine: acute myocardial infarction, disseminated intravascular coagulation, immune thrombocytopenia, and pulmonary embolism.
No comments:
Post a Comment